University of Cincinnati: Clinical Trials

468 trials sponsored by University of Cincinnati, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

270 completed, 58 unknown, 46 recruiting, 32 terminated. 161 Not applicable, 76 Phase 2, 71 Phase 4, 63 Phase 3, 27 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable161Completed 83, Recruiting 22, Unknown 22, Active not recruiting 15, Not yet recruiting 6, Terminated 6, Withdrawn 4, Enrolling by invitation 3
Phase 276Completed 48, Terminated 8, Recruiting 6, Withdrawn 6, Active not recruiting 4, Unknown 4
Phase 471Completed 46, Unknown 13, Terminated 5, Recruiting 3, Withdrawn 3, Enrolling by invitation 1
Phase 363Completed 39, Terminated 9, Active not recruiting 6, Unknown 3, Recruiting 2, Withdrawn 2, Enrolling by invitation 1, Not yet recruiting 1
Phase 127Completed 15, Terminated 3, Unknown 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Suspended 1, Withdrawn 1
Early Phase 17Completed 3, Recruiting 3, Unknown 1

Follow University of Cincinnati: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Self-administered Acupressure in Patients With Sickle Cell Disease
Verum Acupressure (using AcuWand), Sham Acupressure (using AcuWand) - Sickle Cell Disease (SCD)
Not applicableNot yet recruitingUniversity of Cincinnati3002027-10-012026-10-15
Self-administered Neurostimulation Intervention for Firefighter Traumatic Stress to Reduce Alcohol Use: Pilot Study
Transcutaneous auricular neurostimulation (tAN), Active Sham - Posttraumatic Stress Symptoms, Heavy Alcoholic Consumption
Not applicableNot yet recruitingUniversity of Cincinnati202027-09-012026-10-09
Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma
NaviFUS System, Lumason, Bevacizumab - GBM
Not applicableNot yet recruitingUniversity of Cincinnati102026-12-012026-06-04
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
Minocycline, Placebo - Sickle Cell Disease, Cognitive Impairment
Phase 1Not yet recruitingUniversity of Cincinnati302026-12-012026-05-14
Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring
Continuous glucose monitor - Type 2 Diabetes
Not applicableNot yet recruitingUniversity of Cincinnati2182026-11-012026-10-22
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe
Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV
Not applicableRecruitingFred Hutchinson Cancer Center3002026-10-152026-10-19
Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda
Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV
Not applicableRecruitingFred Hutchinson Cancer Center3002026-10-152026-10-19
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa
Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV
Not applicableRecruitingFred Hutchinson Cancer Center2002026-10-152026-10-20
Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya
Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV
Not applicableRecruitingFred Hutchinson Cancer Center3002026-10-122026-10-20
Cilostazol for Prevention of Recurrent Stroke Trial
Cilostazol 100 mg Tablets, Placebo - Stroke Recurrence, Myocardial Infarction
Phase 3Not yet recruitingStanford University20002026-10-012026-10-15
Promoting Adherence to Chemotherapy Handling Guidelines Among Oncology Nurses
The Workplace program to Improve the Safe Handling of hazardous drugs (WISH) - Chemotherapy Exposure, Handling Guidelines
Not applicableNot yet recruitingUniversity of Cincinnati602026-10-012026-09-03
Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
needling acupuncture, laser acupuncture - Sickle Cell Disease, Pain
Not applicableRecruitingUniversity of Cincinnati1202026-07-012026-08-12
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
IONM procedure - Breast Cancer, Surgery
Not applicableRecruitingUniversity of Cincinnati62026-06-292026-07-01
Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment
Resisted walking - Stroke
Not applicableRecruitingUniversity of Cincinnati182026-06-252026-07-06
Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies
Pelvic floor physical therapy - Cervical Cancer, Radiation Therapy Complication
Not applicableRecruitingUniversity of Cincinnati282026-04-162026-04-23
Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction
Tranexamic Acid (TXA), Placebo - ACL Injury, ACL Tears
Phase 4WithdrawnCampbell Clinic2026-04-012026-03-03
Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth
N-acetylcysteine, Mindfulness-based cognitive therapy, Placebo - Mild Depression
Phase 3RecruitingUniversity of Cincinnati1602026-02-262026-03-11
Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation
Pendulum Glucose Control (PGC) - Radiation Injuries
Early Phase 1RecruitingUniversity of Cincinnati202026-01-292026-02-05
Healthy Eating for My Infant: A Community- Informed Infant Obesity Prevention Program Addressing the Impact of Maternal Mental Health on Eating and Feeding
Healthy Eating for My Infant (HEMI) - Obesity & Overweight
Not applicableEnrolling by invitationUniversity of Cincinnati602026-01-292026-06-11
Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors.
Virtual Reality System, Word Search Puzzles - Brain Cancer
Not applicableNot yet recruitingUniversity of Cincinnati402026-01-012026-01-02

Showing 20 of 468. Sign in to see all of them.

Conditions studied

Stroke (31)  ·  Bipolar Disorder (23)  ·  Depression (19)  ·  Ischemic Stroke (17)  ·  Sarcoidosis (14)  ·  Anxiety Disorders (11)  ·  Brain Injuries, Traumatic (11)  ·  Binge-Eating Disorder (10)  ·  Obesity (9)  ·  Opioid-Related Disorders (9)  ·  Acquired Immunodeficiency Syndrome (8)  ·  Attention Deficit Disorder with Hyperactivity (8)  ·  Brain Neoplasms (8)  ·  Parkinson Disease (8)  ·  Substance-Related Disorders (8)

Interventions

Sugars (12)  ·  Quetiapine Fumarate (10)  ·  Mycophenolic Acid (9)  ·  Sirolimus (7)  ·  Docosahexaenoic Acids (6)  ·  Methylphenidate (6)  ·  Tacrolimus (6)  ·  Escitalopram (5)  ·  Prednisone (5)  ·  Radiotherapy (5)  ·  Standard of Care (5)  ·  thymoglobulin (5)  ·  Bevacizumab (4)  ·  Duloxetine Hydrochloride (4)  ·  Gemcitabine (4)

Countries

United States (434)  ·  Canada (13)  ·  China (3)  ·  United Kingdom (3)  ·  Japan (2)  ·  South Korea (2)  ·  Zimbabwe (2)  ·  Australia (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Iceland (1)  ·  India (1)  ·  Italy (1)  ·  Kenya (1)  ·  Lithuania (1)

Top investigators

Robert P Baughman, MD (11)  ·  Michael V Knopp, MD, PhD (9)  ·  Robert McNamara, PhD (7)  ·  Theresa Winhusen, Ph.D. (6)  ·  Theresa Winhusen, PhD (6)  ·  E. Steve Woodle, MD (5)  ·  Melissa DelBello, MD (5)  ·  Melissa P DelBello, MD (5)  ·  Susan L McElroy, MD (5)  ·  Susan L. McElroy, MD (5)  ·  Francis X McCormack, MD (4)  ·  Leeya Pinder, MD, MPH (4)  ·  Margaret M Madeleine, PhD, MPH (4)  ·  Rachel L Winer, PhD, MPH (4)  ·  Alberto Espay, MD (3)

Results publications

PMID 35585125, PMID 37166980, PMID 42064927, PMID 10580682, PMID 10601925, PMID 11454660, PMID 1244564, PMID 12679447, PMID 15089868, PMID 15598683, PMID 15671108, PMID 16886975, PMID 17194267, PMID 17195176, PMID 17229469, PMID 1732972, PMID 17388708, PMID 18055726, PMID 18251624, PMID 18263672, PMID 18339115, PMID 18346503, PMID 18816238, PMID 18828701, PMID 18928997, PMID 18957534, PMID 18974308, PMID 19042026, PMID 19054418, PMID 19222415, PMID 19357528, PMID 19805702, PMID 19877975, PMID 19898966, PMID 19963274, PMID 20105415, PMID 20130094, PMID 20209489, PMID 20219292, PMID 20361901, PMID 20492837, PMID 20560291, PMID 20598843, PMID 20861739, PMID 21048095, PMID 21080416, PMID 21180274, PMID 21262990, PMID 21401993, PMID 21410393

NIH funding

U10DA013732 (5), U24CA275417 (4), UG1CA275402 (4), U54HL127672 (3), P01CA096964 (2), R01HD093694 (2), 1OT2NS129366-01 (1), 1UG3NS133209-01A1 (1), 1UL1TR001425-01 (1), 3UG1DA049444-04S2 (1), 4UH3NS119702-02 (1), 4UH3TR000961-02 (1), 5UG1CA284671-03 (1), 5UG1CA284918-03 (1), 5UG1DA049444 (1)